Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma
Cancers · 03.06.2026 · 18 (11) · 1830
DOI: 10.3390/cancers18111830 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.06.2026. Verfasst von Taylor L Garza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of South Florida, Tampa, FL 33606, USA. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Roughly 100,000 new cases of melanoma are diagnosed yearly in the United States, the majority of which are early-stage disease with excellent prognosis. However, a subset of patients harbors clinically occult aggressive biology that can go undetected on standard clinicopathologic analyses. Gene expression profiling (GEP) assays have emerged as molecular adjuncts to risk stratification, aiming to improve sentinel lymph node biopsy (SLNB) decision-making and surveillance planning. Two commercial tests are widely available: the 31-gene expression profile (31-GEP, DecisionDx-Melanoma, Castle Biosciences) and the clinicopathologic gene expression profile (CP-GEP, Merlin, SkylineDx). This review summarizes the current evidence for each assay regarding their performance and utility, with a focus on potentially actionable use cases, limitations, and the practical context in which these tools are most valuable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of South Florida, Tampa, FL 33606, USA.
- Cancer Institute, Tampa General Hospital, Tampa, FL 33606, USA.
ORCID-Profile: Taylor L Garza, Jae Hwan Choi, Edmond Box, Richard Jacobson
Zitieren
APA
Garza, T. L., Choi, J. H., McGee, M., Box, E., Nywening, T., Karachristos, A., Schwarzberg, A., Fishman, M., & Jacobson, R. (2026). Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma. Cancers, 18(11), 1830. https://doi.org/10.3390/cancers18111830
Vancouver
Garza TL, Choi JH, McGee M, Box E, Nywening T, Karachristos A, et al. Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma. Cancers. 2026;18(11):1830. doi:10.3390/cancers18111830
BibTeX
@article{Garza2026,
author = {Garza, Taylor L and Choi, Jae Hwan and McGee, Michelle and Box, Edmond and Nywening, Timothy and Karachristos, Andreas and Schwarzberg, Abraham and Fishman, Mayer and Jacobson, Richard},
title = {Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1830},
doi = {10.3390/cancers18111830}
}
EUVIMED